AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 200 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $59,000 | +883.3% | 1,244 | +551.3% | 0.00% | – |
| Q3 2019 | $6,000 | -84.6% | 191 | -75.9% | 0.00% | – |
| Q2 2019 | $39,000 | -51.2% | 791 | -33.8% | 0.00% | -100.0% |
| Q1 2019 | $80,000 | +45.5% | 1,195 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $55,000 | -20.3% | 1,195 | +33.1% | 0.00% | 0.0% |
| Q3 2018 | $69,000 | -8.0% | 898 | +0.7% | 0.00% | 0.0% |
| Q2 2018 | $75,000 | +2.7% | 892 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $73,000 | +329.4% | 892 | +197.3% | 0.00% | – |
| Q4 2017 | $17,000 | +30.8% | 300 | -7.1% | 0.00% | – |
| Q2 2016 | $13,000 | – | 323 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 3,057,869 | $86,477,000 | 2.23% |
| Eagle Health Investments LP | 329,713 | $9,324,000 | 2.14% |
| Bellevue Group AG | 4,058,792 | $114,783,000 | 1.65% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 959,214 | $27,127,000 | 1.13% |
| ARMISTICE CAPITAL, LLC | 1,924,000 | $54,411,000 | 0.94% |
| Integral Health Asset Management, LLC | 100,000 | $2,828,000 | 0.55% |
| Monarch Partners Asset Management LLC | 57,820 | $1,635,000 | 0.49% |
| ArrowMark Colorado Holdings LLC | 1,380,389 | $39,037,000 | 0.48% |
| AlphaCentric Advisors LLC | 15,000 | $424,000 | 0.44% |
| PDT Partners, LLC | 72,778 | $2,058,000 | 0.31% |